CN Stock MarketDetailed Quotes

300016 Beijing Beilu Pharmaceutical

Watchlist
  • 6.26
  • +0.14+2.29%
Market Closed Jan 20 15:00 CST
3.08BMarket Cap-62.60P/E (TTM)

Beijing Beilu Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beijing Beilu Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2020/FY827.338M / 1.029B--
--2019/FY819.119M / 794.000M--
DatePeriodRevenue/EstimateEarnings Call
--2020/FY827.338M / 1.029B--
--2019/FY819.119M / 794.000M--
--------
--------
--------

Unlock Free Earnings Estimates

Beijing Beilu Pharmaceutical Earnings Reports

  • Hokuriku Pharmaceutical: Third quarter report 2024

    Oct 29, 2024 12:00 ET

  • Hokuriku Pharmaceutical: Semi-Annual Report 2024

    Aug 27, 2024 12:00 ET

  • Hokuriku Pharmaceutical: 2024 Semi-Annual Report Summary

    Aug 27, 2024 12:00 ET

  • Hokuriku Pharmaceutical: Annual Report 2023

    Apr 21, 2024 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 20, 2025

    Buy

    • Strong Buy

      0.00%

    • Buy

      100.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Innovative Drugs
    Innovative Drugs
    Intraday+2.07%
    Brain science (brain-computer interface)
    Brain science (brain-computer interface)
    Intraday+1.71%
    Biomedical
    Biomedical
    Intraday+1.50%